chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I woke up with distorted vision, possibly an ocular migraine.  Went to loss of peripheral vision in my left eye and was left with a headache for the next 24 hours.
TIRED, HEADACHE, SLEEPY, COLD, FEVER, EXHAUSTED. DOESN'T WANT TO EAT OR DRINK ANYTHING. COLD AND HOT (KEPT GOING ON AND OFF) AND JUST WANT TO SLEEP. COUGHING, RUNNING NOSES AND REDNESS AROUND THE EYES. HE FELT TENDER AT THE INJECTION SITE RIGHT AFTER THE SHOTS. MMRV, FLU, POLIO, DTAP. VERY EMOTIONAL. JUST TEARS ROLLING DOWN HIS CHEEKS AND DOESN'T WANT TO DO ANYTHING AT ALL.
HEART PALPITATIONS; ELEVATED HEART RATE; LOSE OF APPETITE; LOSS OF SLEEP; BURNING  SENSATION IN SHOULDER; LOSS OF ABILITY TO WALK; TINGLING IN ARMS AND HAND; HANDS WENT NUMB; This spontaneous report received from a consumer concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced heart palpitations, elevated heart rate, lose of appetite, loss of sleep, burning sensation in shoulder, loss of ability to walk, tingling in arms and hand, and hands went numb. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the heart palpitations, elevated heart rate, lose of appetite, loss of sleep, burning sensation in shoulder, hands went numb, loss of ability to walk and tingling in arms and hand was not reported. This report was non-serious.
TROUBLE BREATHING; CONGESTION; FEVER; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 20-APR-2021 19:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 21-APR-2021, the subject experienced fever. On 04-MAY-2021, the subject experienced trouble breathing. On 04-MAY-2021, the subject experienced congestion. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from trouble breathing, and congestion on 07-MAY-2021, and fever on 21-APR-2021. This report was non-serious. This case, from the same reporter is linked to 20210432473 and 20210428876.
Fatigue, , Body aches, Swollen hands (noted on the 27th), Death (31st)
Redness, swelling, pain that includes the whole arm, fever, and general not feeling good.
This will probably just be filed away and forgotten about, but I have some serious concerns about the HPV vaccine, GARDASIL 9, and whether or not I have permanent damage because of it. I received the first dose when I was 9 year-old, then a big media scare turned my mom off from getting me the rest of the series(bless her soul). I'm 22 now and decided to finish the series or restart it. I got my second dose over a month and a half ago and my arm (the site of injection) is still stiff and sore. Why is this? I've seen other people online comment with the same side effect. Do the creators of this vaccine even truly know its affects/aids effects? I'm terrified it will never go away and I could develop other underlying side effects. The doctors don't know why my arm is still sore, does anyone?
Pt had second dose, moderna 0001C21A on 4/26/21  in L arm at Center.  Pt started having palpitations and tachycardia on 6/20/21 and had recorded HR up to 107-188 at rest.  Pt has since had EKG, Holter and Echocardiogram, is awaiting cardiology consultation.  Symptoms continued after her booster, Pfizer FJ6393 given 1/15/22  (given at Pharmacy).  Pt continues with symptoms of tachycardia and arrhythmia.
patient reported to pharmacy on 12/18 around 4:30 pm to show injection site reaction. Patient states injection site reaction started the next day -- increased redness, swelling, & warmth at injection site. Patient was counseled to take benadryl as needed for reaction along with a warm compress
Instantly felt shot material go through veins on L side of chest, 15 minutes later extremely light headed, 10 min later L side of face become numb, headache, 30 min later L arm swelled to side of 1/2 of baseball, lymph nodes under L arm and on L collar bone became enlarged.  Arm swelling lasted 4 weeks, Lymph nodes have not gone down and it has been 5 wks, Advised by Nurse Practioner at Pharmacy advised me not to get 2nd shot. I am extremely healthy and work  5 days/wk, workout at gym 3x /wk Weights and Total Body Lift classes.  Sided effects were a major surprise!
pt recvd Hep B vax on 22APR92 & 20MAY92 & on 21MAY exp neck pain & stiffness, shoulder pain; approx 22MAY92 exp inc weakness in limbs & some staggering; recovered in 2 to 3 days;
Patient started complaining that his leg was hurting. It got progressively worse, until he couldn't walk on his leg and I couldn't touch anywhere from his hip to his knee on the leg where he got the injection. Throughout the night, if the sheet even brushed his leg, he would wake up screaming in pain.
Covid-19 treatment; Covid-19 treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 24Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 41 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "PCOS" (unspecified if ongoing); "fibromyalgia" (unspecified if ongoing); "psoriasis" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "Covid-19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment; Negative, notes: symptoms 4 days after testing negative. Therapeutic measures were taken as a result of drug ineffective, covid-19 which includes Paxlovid treatment from 26May2023 to 31May2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Pt states that the night after the vaccine, he was short of breath and unable to exercise as normal.  He is a very active man, exercises daily.  He stated that he was weak with body aches.
Parent states child cried for a few hours and "stiffened up" the evening after he received his immunizations. The same thing happened after his 2nd round of immunizations on 12/15/2014.
"History obtained from: patient   Patient is a 28 y.o. male with hx of post-viral myopericarditis in 2013 but otherwise healthy who presents for recurrence of myopericarditis incidentally not long after receiving 2nd COVID vaccine    Got the 2nd COVID vaccine on Sunday. Monday felt fevers and chills and malaise all day. Tuesday morning felt some retrosternal chest discomfort that lasted an hour or so and spontaneously went away. Was able to go to work all day and do fine. Works in a garage and lifts heavy tires. Yesterday took kids to day care, felt a little pain that morning which resolved. Picked them up in the evening and was going to hang out with them but had recurrence of pain and this time was quite severe. Tried to take some tylenol but threw this up. Came to the ED and had to wait 1-2 hours to be seen, but the time he was his pain had nearly resolved. Troponin taken around 10000. Cardiology consulted, think this might be reactivation / recurrence of his prior myopericarditis." H&P 3/24/21  "This is a 28 y.o. male with hx of post-viral myopericarditis in 2013 but otherwise healthy who presents for recurrence of myopericarditis incidentally not long after receiving 2nd COVID vaccine                         # Myopericarditis             Had episode of post-viral myopericarditis back in 2013, at which time he had an elevation of Trop I (non-HS variety) to 7.3 and echo showing basal inferolateral, basal inferior and mid inferolateral wall motion abnormalities but otherwise normal LV function. Has been highly functional. Recently got 2nd COVID vaccine and had fevers/chills after that.             Recurrent chest pain 3/24 w/o provocation, aborted on its own but has trop elevated to 10,000. EKG does not show STEMI and patient actually asymptomatic in ED. No infectious symptoms. Unclear but wonder if COVID vaccine could have caused recurrence of prior myopericarditis? Cards called in ED, they would like him admitted, to treat with colchicine and advil, repeat TTE and they will consult in the morning." A/P 3/24/21 from admission
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 36 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2 , single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "pulmonary emboli" (unspecified if ongoing); "obesity" (unspecified if ongoing); "herniated discs cervical and thoracic" (unspecified if ongoing). Concomitant medication(s) included: CLONIDINE; ELIQUIS; METOPROLOL; SPIRONOLACTONE; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; LOSARTAN; HYDROCHLOROTHIAZIDE; PREVACID; TYLENOL; SYMBICORT. Past drug history included: Ativan, reaction(s): "Known allergies: Ativan", notes: Known allergies: Ativan.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Indication: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient received treatment with Paxlovid for COVID-19 (Treatment start date: 08Jul2022 Treatment stop date: 13Jul2022).  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The reported COVID-19 positive after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration.
This spontaneous report as received from a pharmacist refers to a 68 year old female patient with no medical history and no drug reactions/allergies. On 31-MAY-2013 the patient was vaccinated with ZOSTAVAX (lot # J000429, Exp date as 10-APR-2014, 0.65 ml, subcutaneous. On an unspecified date in June 2013, "a few days later, she was working in her yard and developed a poison oak/ivy rash on her hands and lower arms". The pharmacist reported that the patient went to an unspecified physician who visually inspected  the rash ans stated "the rash was either poison oak or poison ivy" and the unspecified physician advised her to use "topical corticosteroid cream". No lab diagnostics studies were performed. VZVIP packet faxed. The outcome of poison oak/ivy rash on her hands and lower arms was reported as not recovered/not resolved. Additional information has been requested.
Information was obtained on a request by the Company from the agency (HA# 376407) via a Public Case Detail concerning a 43 year old female. Patient medical history, concurrent conditions and concomitant medications were not reported. The patient past vaccination history included 1st dose of RECOMBINANT (manufacture unknown) on an unknown date and 2nd dose RECOMBINANT (manufacturer unknown) on an unknown date. On an unknown date in 1993, the patient was vaccinated with third dose of RECOMBINANT (manufacturer unknown) (dosing details not provided) (also reported as it was unclear if 3 doses or a single dose of triple antigen Hepatitis B vaccine administered). Subsequently, since an unknown date, the patient experienced seizures and arching of back for 6 months and had experienced tinea, eczema, gut problems, irreparable neurological damage, a brain tumor, brain inflammation, problems with bones and joints, muscle tension, an inability to heal after injury, spasms in response to electricity and perfume, an inability to walk, an inability to go out in public and eat in public without being sick and multiple organ failure. The doctor advised her to avoid consuming protein and fats. The outcome of the events are reported as unknown. The agency considered the events to be possibly related to vaccination with RECOMBINANT (manufacture unknown). Upon internal review, the events of multiple organ dysfunction syndrome, brain neoplasm, abasia and seizure were determined to be medically significant. Additional information is not expected as no follow up is expected from the agency.
Severe body aches/chills/nausea/headache lasting >24 hours.  Symptoms began to subside >36 hours.
Was given zantac for his stomach; Little hivey (second episode); Getting hives (first episode); Since getting moderna covid-19 vaccine patient experienced an increase in fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Was given zantac for his stomach), URTICARIA (Little hivey (second episode)), URTICARIA (Getting hives (first episode)) and FATIGUE (Since getting moderna covid-19 vaccine patient experienced an increase in fatigue) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RAVULIZUMAB (ULTOMIRIS [RAVULIZUMAB]) for aHUS.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and RAVULIZUMAB (ULTOMIRIS [RAVULIZUMAB]) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Was given zantac for his stomach), URTICARIA (Little hivey (second episode)), URTICARIA (Getting hives (first episode)) and FATIGUE (Since getting moderna covid-19 vaccine patient experienced an increase in fatigue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE for Abdominal discomfort, at an unspecified dose and frequency; CORTISONE for Abdominal discomfort, at an unspecified dose and frequency and RANITIDINE HYDROCHLORIDE for Abdominal discomfort, at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISCOMFORT (Was given zantac for his stomach), URTICARIA (Little hivey (second episode)) and FATIGUE (Since getting moderna covid-19 vaccine patient experienced an increase in fatigue) outcome was unknown and URTICARIA (Getting hives (first episode)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For the co-suspect Ultomiris(ravulizumab), the concentration was 250cc bolus of fluid. No concomitant medications was provided. On an unspecified date, the patient experienced an increase in fatigue (FATIGUE) since getting Moderna COVID vaccine. The patient had also noticed increase fatigue since starting ravulizumab. The patient reported getting hives (URTICARIA) (first episode) with his first dose but received medications (unspecified) and had not had reaction since then. The patient reported getting a little hivey (URTICARIA) (second episode) after his second ravulizumab dose to back of arms and around his face. Corrective treatment included unspecified medications for the event of urticaria and not reported for fatigue.   Reporter did not allow further contact
Patient was due for a Dtap and IPV, we do not have IPV in the office. I asked Dr  if I could give Kinrix and he said yes. I gave it with my providers permission.  The patient is fine, has not experienced any adverse outcomes.
blanched fainted w/eyes open pupils unchanged;10 seconds LOC BP 90/40, P72, 820cc sunny delight BP 72/40, P84 FNP examined # 150PM BP 110/60, P80 hx of LOC referred to MD;
3 to 5 days after this shot she began to develop Eczema on her arms and legs. Began to have cold like symptoms as well that last 5 days.
This spontaneous report as received from a health professional refers to a 8 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 17-NOV-2015, the patient was vaccinated with an improperly stored dose of VARIVAX lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt recv vax on 3/27/98; on same day pt exp severe arm pain; pt was unable to move arm.Pt seen in clinic; tx=immobilizer &Keflex.
Patient was vaccinated 2/12/21, 3/5/21 and 12/15/21 with the Pfizer vaccine Patient was diagnosed 1/3/22 with COVID-19  Received Death Abstract stated patient died 1/17/2022 at 05:34 at her living place.  No Web report listing a hospitalization was received by the health department  No further information is known  Please contact the facility for any additional information
Patient stated she was having some flushness in the face and some itching. No swelling, tongue swelling, fever, or headaches. No trouble breathing. Patient has had anaphylactic reactions before and stated this was not a repeat of that.  Just mainly the itching and she described it as a "cortisol flush".
Client was 15 years old at time of vaccination of first vaccination on 3/16/21. Client received 2nd dose today, 4/6/21. Consent was completed and signed by guardian with age listed as 16 years old. Birthdate was not verified by staff prior to injection.
No event; dose administered at 2 months old; This spontaneous report was received from a physician and refers to a 2 month old female patient. Patient had none concurrent conditions or medical history. Concomitant medications included of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (2307USA009420), diphtheria vaccine toxoid, hib vaccine conj (tet tox), pertussis vaccine acellular 5-component, polio vaccine inact 3v (mrc 5), tetanus vaccine toxoid (PENTACEL), pneumococcal vaccine conj 7V (crm197)(PREVNAR) and PEPCID (unspecified component).     On 06-JUN-2023, the patient was vaccinated with a dose of included hepatitis b vaccine (manufacturer unknown) (lot #, expiration date, strength, route of administration, anatomical location not provided) as prophylaxis, when she was 2 months old (inappropriate schedule of product administration). No adverse effects reported.  This is one of 2 reports from the same patient.
Tiredness,Fatigue; Not as active; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness,Fatigue) and SLUGGISHNESS (Not as active) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 27-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced FATIGUE (Tiredness,Fatigue) and SLUGGISHNESS (Not as active). At the time of the report, FATIGUE (Tiredness,Fatigue) and SLUGGISHNESS (Not as active) outcome was unknown.            Concomitant medications were not provided by the reporter. Treatment Medications were not provided by the reporter.   Reporter did not allow further contact
Pain, swelling, redness, and heat at vaccination site 7.5 days post vaccination. I was just fine (my arm hurt a bit the first day or two after vaccination), and I responded to the V-safe app survey every day for 7 days. The last V-safe survey I received was at 4:30 PM on 2/8, and my arm started to hurt again around 7 PM. I woke up in the morning, and my entire tricep was swollen, red, hot, and painful. Not terribly so, but like 2 days post-vaccine. I took some Advil, and that helped the discomfort but not the swelling or redness. I tried *every other way I could think of* to get this information to the CDC, but they're not making it easy. V-Safe doesn't allow for additional input beyond the surveys, the email contact sheet on the CDC website is nonsense, and this seemed the only way to get this out there. Anyway, it's not life-threatening, but it is weird and uncomfortable and not something I'd read about as a possibility (having this redness/swelling so long after the vaccine). Thank you!
I developed very high fever by the late evening of the same day.  It lasted all night and on the next day, going up to 102.4 F. No other flu symptoms, like cough or sneezing. Very strong headache that does not go away with taking aspirin.
EYE PAIN; SWELLING; NASAL PAIN; RASH; CELLULITIS; A spontaneous report has been received from the regulatory authority (MA). The report concerns a female patient of Unknown ethnic origin (age 11 years).    No medical history was reported. The following demography was reported for the patient's parent:   Sex: Unknown    No concomitant products were reported.    The patient received Fluenz Tetra (influenza virus vaccine live, intranasal) once/single administration, via nasal route, for routine childhood immunisation on 24-Oct-2019.     On 08-Nov-2019, the patient experienced cellulitis (preferred term: Cellulitis). On an unknown date, the patient experienced eye pain (preferred term: Eye pain), swelling (preferred term: Swelling), nasal pain (preferred term: Rhinalgia) and  rash (preferred term: Rash).     The outcome of the events of eye pain, swelling, nasal pain, cellulitis and rash was unknown.     The events eye pain, swelling, nasal pain, cellulitis and rash were considered serious (hospitalised) by reporter.     ; Sender's Comments: Eye pain, swelling, rhinalgia and cellulitis are not listed in the company core data sheet for Q/LAIV (Fluenz Tetra). Reported cellulitis could be contributory for swelling, eye pain and rhinalgia. Due to limited information on exact location of swelling and cellulitis, exact onset date of events, concurrent diseases, concomitant medication, relevant medical history, risk factors (injury, weakened immune system, skin condition, obesity), etiologic and diagnostic workup, it is not possible to make conclusive assessment of causal relationship of events with suspect drug.